VF
BDTX icon

Virtu Financial’s Black Diamond Therapeutics BDTX Stock Holding History

Virtu Financial’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,415
Closed -$39K – 1675
2025
Q3 		$39K Buy
+10,415
New +$30.5K ﹤0.01% 1169
2022
Q4 		– Sell
-10,703
Closed -$18K – 1612
2022
Q3 		$18K Buy
+10,703
New +$33K ﹤0.01% 1416
2022
Q1 		– Sell
-22,664
Closed -$121K – 1499
2021
Q4 		$121K Buy
+22,664
New +$158K 0.01% 1048

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's BDTX Position: Q4 2025 in Review

Virtu Financial sold out of Black Diamond Therapeutics (BDTX) in Q4 2025, closing a stake of 10,415 shares — an estimated $39K sold.

Virtu Financial first reported a position in BDTX in Q4 2021 and held it in 3 quarters. The position peaked at $121K in Q4 2021. 104 funds tracked by Wall St. Rank hold BDTX as of Q4 2025.

  • Virtu Financial reported no remaining Black Diamond Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 10,415 Black Diamond Therapeutics shares in Q4 2025, an estimated $39K.
  • Virtu Financial first reported a position in Black Diamond Therapeutics in Q4 2021 and held it in 3 quarters.
  • Virtu Financial's Black Diamond Therapeutics position peaked at $121K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.